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ABSTRACT 
BACKGROUND:   
Lateral epicondylitis is the commonest chronic disabling painful 
condition of the elbow. Elbow pain and tenderness with resisted wrist extension 
are common manifestations in lateral epicondylitis. Recent studies have 
suggested platelet rich plasma (PRP) to be a safe and effective therapy for 
tennis elbow. 
PURPOSE:  
To compare the effectiveness of single dose injection of autologus 
platelet rich plasma with corticosteroid injection in treatment of lateral 
epicondylitis and to measure the outcome in a short term follow up study. 
STUDY DESIGN: 
Randomized controlled trial 
METHODS: 
A total of 40 patients with lateral epicondylitis were treated at 
Coimbatore Medical Hospital, April 2014 to June 2014 over 3 months. All 
patients had minimum three months of symptoms. Randomization and 
allocation to the trial group were carried out by a lot method. The platelet rich 
plasma (PRP) was prepared from venous whole blood.  After receiving a local 
anesthetic, all patients had single dose injection of autologus platelet rich 
plasma with corticosteroid injection in their extensor tendons at elbow. Patients 
received either an autologous platelet rich plasma injection or a corticosteroid 
injection through a peppering needling technique. The primary analysis 
included visual analog scale (VAS) pain scores and Disabilities of the Arm, 
Shoulder and Hand (DASH) outcome scores 
RESULTS:  
The PRP group was more often successfully treated than the 
corticosteroid group. When baseline VAS and DASH scores were compared 
with the scores at 12 weeks follow up, both groups showed improvement across 
time (intention-to-treat principle). However, the VAS and DASH scores of the 
corticosteroid group have not shown improvement, while those of the PRP 
group showed improvement at the end of 12 weeks (as treated principle). There 
were no complications related to the use of PRP. 
 
CONCLUSION:  
Treatment of patients with lateral epicondylitis with PRP reduces pain 
and increases function significantly, exceeding the effect of corticosteroid 
injection at the end of 12 weeks follow up. Future decisions for application of 
PRP for lateral epicondylitis should be confirmed by more number of patients 
and further follow up  and should take into account possible costs and harms as 
well as benefits. 
KEYWORDS: 
lateral epicondylitis; platelet; platelet rich plasma (PRP);corticosteroid; 
tennis elbow. 
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INTRODUCTION 
 
1. INTRODUCTION 
Lateral epicondylitis is an inflammatory condition that occurs at 
the origin of the common extensor tendon of forearm over the lateral 
epicondyle. It is the commonest chronic disabling painful condition of the 
elbow. It causes symptoms in   1% to 3% of the general population. It is 
common in people whose occupation requires frequent rotary motion of 
the forearm like carpenter, gardener, computer workers and knitting 
workers. The age of onset of lateral epicondylitis is between 35 and 50 
years with an equal male to female sex ratio. The dominant upper limb is 
most commonly affected [1,2,3]. 
           The actual cause of lateral epicondylitis is not clearly understood. 
Now it is considered that degenerative process occurs at the common 
extensor tendon origin of the wrist and fingers due to overuse and 
abnormal microvascular responses [4,5,6]. Nirschl observed that the basic 
pathology was in the origin of the extensor carpi radialis brevis (ECRB) 
tendon. But sometimes the anteromedial edge of extensor digitorum 
communis (EDC) and the deep surface of extensor carpi radialis longus 
(ECRL) may also be involved.  
         Various modalities of treatment have been recommended for lateral 
epicondylitis like rest, activity modification, non steroidal anti 
inflammatory drugs, counterforce braces, massage, physiotherapy, laser 
treatment, extracorporeal shockwave treatment, acupuncture, ultrasound 
treatment and botulinum toxin type A injection. Previously Injection of 
corticosteroids was thought to be the gold standard treatment in lateral 
epicondyliis. The autologus blood injection and different types of open 
and arthroscopic operative treatment are also advised for lateral 
epicondylitis [7,8,9,10,11]. At present, platelet rich plasma (PRP) is 
considered as an ideal biological autologous blood derived component. It 
can be injected to different tissues where, platelet is activated and it 
releases high levels of transforming growth factors-beta (TGF-β), platelet 
derived growth factors (PDGF), fibroblast growth factors (FGF), vascular 
endothelial growth factors (VEGF) and cytokines at the injected site. 
These growth factors released from platelet rich plasma promote healing 
of wound, tendons and bone at cellular level [12].  In addition, platelet 
rich plasma has high antimicrobial potency and this property may prevent 
infections [13]. These details make us to conduct this study.                                                                            
  
 
  
 
 
 
 
 
 
 
 
AIM AND OBJECTIVES 
 
2. AIM AND OBJECTIVES 
 To compare the effectiveness of single dose injection of autologus 
platelet rich plasma with corticosteroid injection in treatment of lateral 
epicondylitis and to measure the outcomes in a short term follow up 
study. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
3. REVIEW OF LITRATURE 
• Smidt N, et al. Corticosteroid injection in tennis elbow: a 
systematic review. Pain. 2002. The author reported 13 randomized, 
controlled studies that documented the positive outcome of 
corticosteroid injection versus placebo injection, local anesthetic drug 
injection and dexamethasone or triamcinolone injection. The results 
showed that there was superior short term outcome in corticosteroid 
injection therapy for tennis elbow in view of pain reduction and grip 
strength, but there was no intermediate or long term beneficial effect 
in this study.                                                                                               
• Altay T, Günal I, Oztürk H. Local injection therapy for tennis 
elbow. Clinical Orthopaedics & Related Research. 2002. The author 
conducted a study using the peppering technique while comparing a 
combined steroid and anesthetic drug injection to only anesthetic drug. 
There was no significant difference among the groups at two, six and 
12 months after injection in regard to provocative testing and 
Verhaar’s Scoring System for the treatment of lateral epicondylitis. 
They attribute to the improved excellent outcome in 93% of patients 
with steroid and 95% without steroid regarding healing of the 
degenerative myxoid tissue that may be stimulated by multiple 
bleeding channels created with peppering technique. 
• Newcomer KL, et al. Corticosteroid injections in initial treatment 
of tennis elbow. Clinical Journal of Sports Medicine 2001. In a 
randomized trial, 19 patients treated with rehabilitative method and a 
placebo injection, and 20 patients treated with rehabilitative method 
and an injection of corticosteroid. No significant difference was 
observed among the two groups on pain questionnaires, visual analog 
score and grip strength at four, eight and twelfth weeks. But both 
groups showed similar improvements in the follow up, with over 80% 
of patients showed better results from baseline to 6 months. 
• Bisset et al. from Australia and Smidt et al. from Netherland 
randomized subjects with lateral epicondylitis to physical therapy, 
corticosteroid therapy, or a wait and see strategy. In these trials, 
corticosteroid therapy showed superior results at six weeks. But in all 
groups there were increased recurrence rates with significantly poorer 
results at one year. In a randomized study, steroid injection is 
compared to naproxen and placebo tablets and steroid injection 
showed better improvement at four weeks, but more than 80% of 
subjects were improved by one year in all groups without significant 
differences. 
• Price et al. conducted a double blinded trial that compared 
various types of steroid injections to lignocaine injection alone. The 
author documented that the initial effect to steroid injection was 
superior to lignocaine injection alone, but at 24 weeks, the results 
were similar. The author also noted that there was worsening of pain 
in post injection period in about 50% of all steroid treated patients. 
• In a study by Dr. Smidt and colleagues, maximum of three 
injections of steroid were superior at six weeks than either 
physiotherapy or a wait and see strategy. The outcome for the 
corticosteroid injections group had declined rapidly at 52 weeks. 
• The combination of ultrasound therapy, deep friction massage, 
and exercise showed significant effect than steroid injections over the 
long term period. Dr. Smidt's study showed that the early response for 
corticosteroid injections was reduced after six weeks. The long term 
effect of corticosteroid injection was 69% compared to the results of 
91% and 83% for the physiotherapy and wait and see approach groups 
respectively, at 52 weeks.  
• A long term outcome study by Dr. Smidt on wait and see 
approach, rest, ergonomic advice and NSAIDS showed the similar 
results as physiotherapy management or corticosteroid injection. "In 
view of our results," concluded Dr. Smidt's group, "we have no reason 
to reach the conclusion that awaiting spontaneous recovery will not be 
the adequate management for the patients with a short period of 
symptoms."  
• After review of four studies on acupuncture treatment, Cochrane 
reviewers published that there was inadequate documents to either 
support or refuse the acupuncture treatment. The British Journal of 
Sports Medicine reviews documented that there was "some evidence" 
for better outcome at two to eight weeks, but the studies were lacking 
in key methodology.  
• Cochrane's review at 14 trials of the short term, topical non 
steroidal anti inflammatory drugs were superior to placebo therapy for 
up to 28 days. The role of oral non steroidal anti inflammatory drugs 
was not clear. There was a few evidence that steroid injections were 
better than oral non steroidal anti inflammatory drugs. "More 
randomized trials are needed," the author concluded.  
•  Runeson L, Haker E. conducted a double blind comparative 
study of Iontophoresis with cortisone in the treatment of lateral 
epicondylitis. Scand J Medical Science Sports 2002. The study with 
adequate methodological quality showed that there was no benefit of 
electromagnetic field management over placebo management. The 
advantages of utilising electrical current to deliver drug to soft tissue 
(iontophoresis) is not clear. There is no evidence that steroid 
iontophoresis is better than saline placebo, and non steroidal anti 
inflammatory drug iontophoresis. Runeson and Haker compared 
corticosteroid iontophoresis with a placebo (saline) iontophoresis 
group and evaluated the results of 12 and 24 weeks. Their reports did 
not favour the use of corticosteroid solution in iontophoresis.  
• A 2002 Cochrane review of a trial comparing braces and other 
orthotics came to a conclusion that although the application of elbow 
braces and other orthotics abounds, the evidence to support them is 
weak. British Journal of Sports Medicine reviewed that the results of 
two studies on orthotics were conflicting and made it difficult to reach 
a definite conclusion. 
• According to the British Journal of Sports Medicine authors, two  
randomized controlled studies on extracorporeal shock wave treatment 
concluded that there is "no added benefit of extracorporeal shock 
wave treatment over that of placebo,"  
•  In a Cochrane review on surgery for lateral elbow pain 2002, the 
authors could not review a single controlled study of surgery for 
lateral epicondylitis. They reported, "Without a control group, it is not 
possible to confirm the effect of surgery in lateral epicondylitis 
treatment."  
• In a double blind randomized controlled study,  the positive 
outcomes of platelet rich plasma versus corticosteroid injections in 
tennis elbow, American Journal of Sports Medicine 2011, 
management of subjects with chronic lateral epicondylitis with platelet 
rich plasma showed significant improvement in pain and functional 
activities, more than the outcome of corticosteroid injections over two 
years follow up. The author documented that the effect of platelet rich 
plasma injection for tennis elbow should be confirmed by further 
follow up from this study and benefits and side effects should be 
documented. 
•  In a randomized controlled study, The Egyptian Rheumatologist 
journal April 2012, comparison of  the effectiveness of injection of 
autologous platelet rich plasma (PRP) and local steroid in reducing 
pain and improving function in a cohort of patients with tennis elbow 
(TE) and plantar fasciitis (PF) studied. Significant differences were 
observed between VAS and DASH scores at base line and 6 weeks 
after treatment in both groups.  Local injection of autologous platelet 
rich plasma (PRP) proved to be a promising form of therapy for tennis 
elbow. It is safe and effective in relieving pain and improving 
function.  
• Peerbooms et al 2010, in a randomized trial in tennis elbow 
treated with platelet rich plasma versus steroid injection: The study 
concluded that, according to the visual analog scale scores, 24 out of 
the 49 subjects (49%) in the steroid group and 37 out of the 51 
subjects (73%) in the platelet rich plasma group were treated 
successfully, which was significantly different. According to the 
Disabilities of the Arm, Shoulder and Hand scores, 25 out of the 49 
subjects (51%) in the steroid group and 37 out of the 51 subjects 
(73%) in the platelet rich plasma  group were treated successfully, 
which was also significantly different. The steroid injection group 
showed better results in early period and then declined after 12 weeks, 
whereas the platelet rich plasma group progressively improved.  
• In a 2003 trial by Edwards with platelet rich plasma  therapy, 
79% of patients in whom nonsurgical treatment like physiotherapy, 
splinting, anti inflammatory drugs and prior steroid injections that had 
failed were completely relieved of pain.                                                                                          
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
LATERAL EPICONDYLITIS 
4. LATERAL EPICONDYLITIS 
 Tennis elbow was first described in the German literature by Runge 
in 1873 and by Major in 1883 [14]. It was named as lawn tennis arm by 
Morries. After that, this name has become common for all painful 
condition at lateral elbow. This condition is usually related to work and 
this condition mostly occurs in non athletes (95%) [15]. 
Anatomy of lateral epicondyle: 
The elbow joint consists of three long bones, namely the humerus, 
ulna and radius. Movements of elbow joint occur at three individual 
articulations. The ulnahumoral articulation is a modified hinge joint that 
permits flexion and extension movement. The radiohumoral articulation 
is a combined hinge and pivot joint that allows flexion and extension 
movement and also rotary movement of radial head on the capitulum. 
During supination and pronation the proximal and distal radioulnar joints 
rotate. The main support for the elbow joint is given by various muscles, 
ligaments and tendons that present around the elbow. The common 
extensor group originate from the lateral epicondyle of the humerus and 
the common flexor group originate from the medial epicondyle of the 
humerus. The brachioradialis and biceps also have attachment around this 
joint. 
      The lateral epicondyle is a pyramid shaped bony prominence. The 
extensor digiti minimi (EDM), supinator, extensor carpi radialis brevis 
(ECRB), extensor digitorum communis (EDC), and extensor carpi ulnaris 
(ECU) form the common extensor tendon. The tendon usually involved in 
lateral epicondylitis is called the extensor carpi radialis brevis [16-23]. 
 
 
 
 
 
 
 
 
 
Lateral epicondyle muscles attachment 
       The anterior surface of lateral epicondyle and supracondylar 
ridge are nearby origin sites for the brachioradialis and the 
extensor carpi radialis longus (ECRL). 
      Another anatomical structure arising from the lateral epicondyle is the 
lateral collateral ligament complex, which is formed by the lateral unlar 
collateral ligament (LUCL), the radial collateral ligament (RCL) and the 
annular ligament. In severe lateral epicondylitis, there is thickening and 
tearing of the lateral ulnar collateral ligament and radial collateral 
ligament along with capsular injury. The extensor carpi radialis longus 
and extensor carpi radialis brevis have a unique relationship at the elbow 
level. The extensor carpi radialis longus overlies the proximal portion of 
extensor carpi radialis brevis such that the extensor carpi radialis longus 
should be raised anteriorly in order to view the superficial surface of the 
extensor carpi radialis brevis. A thin film of areolar connective tissue 
separates these two structures. The origin of extensor carpi radialis longus  
is entirely muscular along the lateral supracondylar ridge of the distal 
humerus. The muscle origin has triangular configuration with the apex 
pointing proximally. In contrast, the origin of extensor carpi radialis 
brevis is entirely tendinous. Although it blends with the origin of the 
extensor digitorum communis, when divided from distal to proximal 
direction and using the tendon undersurface, it can be separated from the 
extensor digitorum communis back to humerus. The attachment of the 
extensor carpi radialis brevis tendon is located just beneath the distal 
most tip of the lateral supracondylar ridge. The footprint is diamond 
shaped measuring approximately 13 by seven millimeter. At the level of 
the radio capitellar joint, the extensor carpi radialis brevis is intimate with 
outer surface of the anterior capsule of the elbow joint, but it is quiet 
easily separable at this level.  
                The radial nerve descends between the brachialis and 
brachioradialis muscle in the distal arm. The radial nerve gives two 
branches, the terminal or deep branch and superficial branch at the level 
of the elbow joint. The terminal branch of the radial nerve is continued as 
the posterior interosseous nerve. The posterior interosseous nerve can be 
compressed at radial tunnel and this condition may cause refractory 
lateral epicondylitis. 
 
 
 
 
  
        
 
 
 
Ligaments attachment on lateral aspect of elbow 
 
 
                  
 
 
 
 
Ligaments attachment in elbow 
Incidence: 
The incidence of tennis elbow is 1 to 3 % in the general population 
per annum. Tennis elbow typically affects the individuals ranging from 
ages of 35 to 50 years with a median of 41 years and it affects equally 
both males and females.  The dominant arm is affected in more than half 
of the patients Populations at high risk are workers whose occupations 
require frequent rotary motion of the forearm like carpenter, gardener, 
computer workers, knitting workers, weight lifting workers and 
construction workers. 95% of lateral epicondylitis occurs in non tennis 
players and 10 to 50 % of regular tennis players are affected by lateral 
epicondylitis symptoms.   
Etiology:
 
The literatures have suggested many theories [16,17,23] about the 
causes of lateral epicondylitis. The significant causes are  
  Extra articular radiohumeral bursitis. 
  Osteochondral radiocapitellar lesion. 
 Posterior interosseous nerve entrapment syndrome or Radial tunnel 
syndrome. 
 Cervical spondylosis and cervical disc disorders at C5-6 or C6-7 
level with referred pain to elbow. 
 Posttraumatic periosteitis. 
        Recently the studies shows the site of lesion starts at the superficial 
and deep fibers of  the extensor carpi radialis brevis (ECRB) involving 
repetitive micro tears or partial tear of the tendon fibers, which develops 
fibrous scar tissue and magnifies the risk of further injury. Few trials 
showed that extensor digitorum cummunis or extensor carpi radialis 
longus or extensor carpi ulnaris were the site of initial injury. Repetitive 
overload, frequent extensor compartment muscles contraction and 
improper gripping techniques of rackets or equipments continue to tear 
the damaged tendon and aggravate the symptoms in lateral epicondylitis. 
Complete tendon ruptures are rare. Since there is no evidence of 
inflammatory activity in the pathological lesion and the word tendinosis 
is preferred over tendinitis or epicondylitis. Tennis elbow with radial 
tunnel syndrome occurs in 5% of patients.  
 Pathophysiology: 
Lateral epicondylitis has three histological changes of tendinosis. 
They are fibroblastic change, vascular granulation and abnormal collagen 
fibers formation. Mechanical overload or a trauma causes fibroblastic 
granulation, which is the early response in elbow tendinosis. Tensile, 
varus and valgus stress within the tendon activate the mechanoreceptors 
(integrins) on the surface of the resting tenocyte and affect these cells, 
when a cleavage plane is created between the tendon fascicles. The 
activated fibroblast starts to increase in numbers and form collagen 
locally [24,25]. 
A few fibroblasts return to their dedifferentiated mesenchymal 
state, whereas other fibroblasts develop chemotaxis and intracellular 
contractile elements. The dedifferentiated fibroblasts develop into 
chondroblasts, osteoblasts, and vascular endothelium [26,27].  This event 
indicates the intrinsic capacity of tendons to attempt to heal the 
tendinosis. It does not prevent the significant contribution of an extrinsic 
source of fibroblasts in tendinosis, but the lack of an effective vascular 
system that causes the failure of healing cycle in tendon repair [28]. 
 Though the humoral process being guided by the immune-based 
inflammatory response, the mesenchymal cell-based process in tendinosis 
lacks the chemical mediators guidance that normally would maintain the 
matrix and the remodeling phase of tendon healing. 
The abnormal vessels in tendinosis are formed by dedifferentiated 
fibroblasts that became mesenchymal cells and then endothelial cells. The 
presence of surrounding fibroblasts could be either an influx of extrinsic 
cells or a local micro environmental population of reprogrammed cells in 
an active fibroblast stage.  The thick abnormal basement membrane and 
the constricted appearance of vessels are seen in tendinosis, and such 
abnormal vessels could be a significant source of extrinsic fibroblasts. 
The pluripotent tendon fibroblast utilise local chemical mediators, which 
it is capable of forming rudimentary blood vessels. Chemical mediators 
of cellular activity are known to be mitomorphogenic substances.  
Cytokines such as platelet derived growth factor-beta (PDGF-β) 
stimulates mitogenesis of fibroblasts, and chemotactic polypeptides like 
transforming growth factor-beta (TGF-β) promotes migration and 
maturation of fibroblasts and angiogenesis [29]. The presence of red 
blood cells inside the abnormal vessels seen in regions of tendinosis 
indicates that vascular granulation is occurred with an extrinsic healing 
process, provided that the immune system receives signals of a need for 
the healing activity.  
Rehabilitative treatment exercises increase regional hyperemia. 
Controlled exercises create cyclical tensile forces that cause the 
remodeling of collagen. Rehabilitation exercise that is programmed for 
patients who have tendinosis of the elbow must concentrate on the 
creation of low impact repetitive tensile forces across the collagen fiber 
matrix and fibroblast system that is the important factor for tendons as a 
structure. Fibroblasts in tendinosis have extreme metabolic activity. The 
capacity for the formation of collagen fiber is high and the collagen in 
tendinosis is primarily type I or type III. These collagens have the similar 
ultra structural configuration, with a sixty four nanometer periodicity and 
a quarter stagger arrangements of filaments. The extracellular alignment 
and cross linking of collagens are not formed in tendinosis [29]. The 
fibroblast driven process normally would be expected to cross link old 
and new collagen in order to contribute to the final stability of the matrix 
[29,30]. Tendinosis tissue contains hyperplasia of nonfunctional vascular 
elements, active distorted fibroblasts and lack of lymphocytes or 
neutophils that is clearly distinct from inflammatory tendinitis and normal 
tendon. The cause of pain in tendinosis correlates with the chemical 
natures of the matrix including the pH level, lactic acid level, and the 
level of prostaglandins.  
 
 
Clinical Presentation: 
 Patient gives history as repetitive grasping or twisting movements 
produces symptoms, and the onset of lateral epicondylitis commonly 
associated without injuries. Usually the symptom starts gradually in 
lateral epicondylitis. Patients are presented with typical complaints of 
localised pain at the lateral epicondyle, sharp nature of pain that is 
aggravated with grasping and rotation movements, morning pain and 
wrist palmer flexion. Some patients may complain weakness or difficulty 
to grip objects. 
The clinical examination of tennis elbow shows the signs of point 
tenderness at the region of common extensor tendon origin and maximum 
tenderness at five millimeter anterior and just distal to the origin of the 
extensor carpi radialis brevis and extensor digitorum communis muscles. 
Other findings are decreased grip strength, restricted supination, and 
dorsiflexion of the wrist. Sometimes weakness of forearm may occur. 
Special Orthopedic Tests:  
        Lateral epicondylitis is diagnosed clinically in many cases. Lateral 
epicondylitis is diagnosed by evaluating 
 History of gradual onset of pain over lateral epicondyle during 
work and sport activities. 
 Pain is aggravated while supinating against resistance and wrist 
dorsiflexion with extended elbow. 
 Point tenderness at the origin of common extensor tendon. 
 Decreased grip strength. 
Cozen's Test or Thomson's test:   
          In the sitting position, after stabilising the affected elbow, the 
examiner palpate along the lateral epicondyle. With closed fist, the 
patient is instructed to pronate the forearm and radially deviate and 
dorsiflex the wrist against the resistance given by examiner. 
      This test is positive when there is pain over the lateral epicondyle or 
muscle weakness or discomfort at elbow. 
Mill's Test:  
           In the sitting position, the examiner palpates over the lateral 
epicondyle of the patient with one arm, while pronating the patient’s 
forearm, palmar flexing the wrist, with the extended elbow with the other 
arm. 
          This test is considered to be positive when there is reproduction of 
pain over the region of the extensor tendon origin at the lateral 
epicondyle. 
 Maudsley’s test: (Resisted third digit extension)  
           The examiner gives resistance while the patient extends the middle 
finger of the hand, stretching the extensor digitorum muscle and tendon 
with one arm, and palpating over the  lateral epicondyle of the patient 
with the examiner's other arm.  
This test is considered to be positive when there is pain over the 
lateral epicondyle of the humerus 
Chair test:  
        This test is described by Gardner. The patient is asked to get up from 
a chair with both hands firmly gripping and pressing the arms of the 
chair. Severe pain felt at the lateral epicondyle of the affected side is 
considered as a positive test. 
 
 
 
Coffee cup test:  
       Coonard has described this test. The patient is instructed to pickup a 
coffee cup by his hand. The test is considered to be positive when there is 
pain over the lateral humeral epicondyle. 
Diagnostic Tests: 
Diagnosis of lateral epicondylitis is commonly based on physical 
examination and the diagnostic tests are not required usually. The 
diagnostic tests are recommended to diagnose the complicated cases to 
identify abnormalities and progression of lesion over the common 
extensor tendon [19,20,31]. Plain radiograph shows soft tissue 
calcification adjacent to the lateral epicondyle in approximately 25% of 
patients, especially if the patient previously had steroid injections. 
Magnetic Resonance Image is recommended to diagnose the intra 
articular pathology, radial collateral ligament integrity and tear at the 
origin of the extensor tendons. Some trials have been conducted to 
identify the sensitivity and specificity of the use of Magnetic Resonance 
Image (MRI) as a diagnostic tool. The sensitivity of Magnetic Resonance 
Image for diagnosis of lateral epicondylitis ranges from 90 to 100 % and 
specificity ranges from 83 to 100 %. Magnetic Resonance Image can 
diagnose edema and thickening in 90 percent of pre treatment 
symptomatic tennis elbow patients. MRI shows tendon thickening with 
increased T1 and T2 signals.     
               
 
 
 
MRI of lateral epicondylitis 
Studies have shown that ultrasongraphy can diagnose symptomatic 
lateral epicondylitis with sensitivity of 72 to 88 percent and specificity of 
36 to 48.5 percent respectively. Ultrasound is utilised to detect 
calcification, tendon thickening and bone irregularities. 
             
 
 
Ultrasongraphy of lateral epicondylitis 
Recently, infrared thermography appears to be a highly sensitive 
tool, with specificity of between 94 to 100 % for the assessment of tennis 
elbow. 
MANAGEMENT: 
Conservative Treatment: 
Literatures have documented the success of treatment of tennis 
elbow with conservative or non operative methods. Recent studies show 
that the success rate might be higher as 89 to 95 percent. The goal of non 
operative management of tennis elbow is to decrease pain and 
inflammation. There are various management modalities for lateral 
epicondylitis, but only a very few studies have been documented on 
which modality has the best outcomes and the long term benefits. The 
non operative treatments for lateral epicondylitis are listed below: 
Wait and watch: 
  Cessation of any painful or aggravating activity, the alteration of 
technique or equipment or modification of workplace reduces pain and 
relieves symptoms of lateral epicondylitis. Cessation of activities is 
advised in the initial period of management for 14 to 21 days. But 
immobilization should not be recommended since it causes disuse 
atrophy of upper limb. For the first two to three weeks RICE (rest, ice, 
compression and elevation) therapy is recommended. The next stage of 
management is continued from six months to one year, according to the 
severity of tennis elbow. At this stage of management, the strength and 
range of movements of elbow are improved and lifestyle modification is 
advised.  
NSAIDS: 
  Non steroidal anti inflammatory medications are useful for acute 
pain relief in lateral epicondylitis. They act by reducing the inflammation 
associated with the acute painful condition. But in chronic condition, 
where the main pathology is degeneration of extensor tendons rather than 
inflammation, its effectiveness seems more of placebo effect rather than 
by its real pharmacological action. Long term intake of analgesics is not 
advisable as it causes gastrointestinal bleeding, renal and liver damage. 
Injection Treatment: 
Various injection therapies have been studied in the management 
of tennis elbow. Corticosteroid, botulinum toxin type A, autologus whole 
blood and platelet rich plasma injections are four therapies being used in 
the treatment of lateral epicondylitis. Studies on corticosteroid injections 
have showed that pain relief starts from five days after initial injection. 
From three months to 12 months, results of corticosteroid injections 
document worsening or the similar outcomes as other lines of 
management. Botulinum toxin type A injection has been studied with 
conflicting results of true clinical benefit. 
Corticosteroid injection: 
Mechanism of action: corticosteroids belong to steroid group. It 
acts by reducing inflammatory reaction thereby decreasing pain. 
Role in lateral epicondylitis: According to recent microscopic studies, 
there are no inflammatory cells in tissues obtained from cases of lateral 
epicondylitis. Therefore the anti inflammatory role of corticosteroids may 
not play a part here except in acute conditions. But the beneficial effects 
of corticosteroids in this condition seem to exist for long time. Probably, 
there must be some other action of steroids in this condition that still it 
remains uncertain. 
Commonly used preparations: 
1. Betamethosone 
2. Dexamethosone 
3. Methyl prednisolone 
4. Triamcinolone acetonide 
Mode of injection:  Injection of steroids is made after palpating the area 
of maximum tenderness. It is usually injected in combination with a local 
anesthetic agent to tolerate the immediate post injection pain. 
Targeted injection may be much beneficial in which the affected tissue is 
localized with ultrasound and then injection given.  
Advantages: 
1. Very effective in acute cases 
2. Even single injection may bring about resolution of the condition 
3. Cost effective 
4. Do not need expensive equipments. 
Disadvantages: 
1. Invasive procedure 
2. Cannot be done in patients with uncontrolled diabetes and 
hypertension. 
3. Side effects are common which includes tendon rupture, fat pad 
necrosis, etc. 
Botulinum toxin injection: 
Botulinum toxin type A injection has been used for lateral 
epicondylitis. It can be injected at the site of maximum tenderness. It has 
increased incidence of side effects. 
Mechanism of action: 
It relieves pain by destroying the pain sensitive nerve fibres. It 
causes muscle relaxation and decreases muscle volume. It also decreases 
central sensitization, sympathetic activity and reduces the accumulation 
of pain mediators like substance-p and glutamate. 
Side effects: 
1. digit paresis 
2. weakness of finger extension 
Autologous blood injection: 
This is injection over the affected tissues with the patient's own 
blood in small quantities. Autologous blood injection was initially done 
by Edwards and Calandruccio in 2004 for tennis elbow with good 
outcome. It was gradually extended for other tendinopathies and chronic 
inflammatory conditions. 
Mechanism of action:  
          Autologous blood when injected into an area of inflammation or 
degeneration tends to provide cellular or humoral mediators and thereby 
initiate inflammatory reaction and brings about healing of the conditions.  
Advantages: 
1. No chance of reactions as the patient's own blood is injected 
2. Cost effective 
3. No need for expensive equipment. 
Disadvantages: 
1. Effect may be short lived 
2. May need multiple injections 
3. Patient may not accept it. 
 
Platelet rich plasma injection: 
Platelet rich plasma (PRP) is blood derived plasma that has high 
concentration of platelets. As an enriched source of autologous platelets, 
platelet rich plasma  possesses several different growth factors and 
cytokines and releases them through degranulation and stimulate healing 
of bone and soft tissue. 
Mechanism of action: 
      Various growth factors and cytokines in the platelet have healing 
potentials and these factors helps to heal the inflammation and 
degeneration at the tendons. 
 
 
 
 
 
 
 
Growth Factors in Platelet rich Plasma 
Growth Factors Function 
Platelet-derived growth factor                Increases cell replication,                                        
angiogenesis, mitogenesis for fibroblasts 
Vascular endothelial growth factor              Angiogenesis 
Transforming growth factor-β                    
 
Main factor in balancing between tissue 
fibrosis and myocyte regeneration                                                                                   
Fibroblast growth factor                             Increases proliferation of myoblasts, 
angiogenesis 
 
Epidermal growth factor                
Increases proliferation of mesenchymal 
and epithelial cells, potentiation of other 
growth factors 
Hepatocyte growth factor                        Angiogenesis, mitogenesis for 
endothelial cells, antifibrosis 
Insulin-like growth factor-1            Increases proliferation of myoblasts and 
fibroblasts, mediates growth and repair 
of skeletal muscle 
Uses: 
1. Lateral epicondylitis 
2. Plantar fascitis 
3. Rotator cuff tear 
4. Degenerative osteoarthrosis 
5. Achilles tendon repair 
6. Anterior cruciate ligament reconstruction 
7. Non union management 
8. Maxillofacial and plastic surgical procedures 
Advantages: 
1. No reaction to injected substances. 
2. More biological form of injection. 
Disadvantages: 
1. Needs centrifugation apparatus. 
2. Requires more amount of blood to be drawn. 
Physiotherapy: 
       Physiotherapy is a commonly prescribed treatment for tennis elbow. 
A standard treatment protocol for physical rehabilitative treatment of 
tennis elbow has not been formed. The aim of physiotherapy concentrates 
on decreasing elbow pain, improving range of motion, grip strength, and 
stretching of the forearm muscles. Studies have documented various 
protocols. Mills and Wadsworth recommended manipulation under 
anesthesia, particularly in patients with concomitant flexion contractures. 
The manipulation involves sudden, forcible, full extension of the elbow 
with the wrist and fingers flexed and the forearm pronated to bring the 
extensor carpi radialis brevis and other extensors under tension. The 
results are excellent if there is audible, palpable snap during 
manipulation.  Cyraix’s protocol uses Mill’s manipulation technique 
combined with deep transverse friction (DTF). Researchers have 
concluded that eccentric strengthening is effective than concentric 
strengthening in tennis elbow. Other methods of physiotherapy for 
management of tennis elbow are ultrasonic therapy and electrotherapies 
(inotophoresis and electromagnetic therapy).      
 
Electrical stimulation and Iontophoresis: 
This works on the principle of ultrasound waves. High voltage 
electrical stimulation diminishes chemical inflammation and reduces pain 
and improves tendon healing. A combination of applying a NSAID or 
steroid cream over the affected area and delivering electrical stimulation 
is known as iontophoresis. Only limited reports are only available to 
support its use. 
Orthoses: 
 
   
 
 
      The recommended types of orthoses are proximal forearm bands and 
cock up wrist splints. The orthoses are used to counteract muscle forces 
of both contraction and tension. Aims of these orthoses are to decrease 
the intrinsic muscular force and tension at the forearm extensor tendons 
in elbow and to give time to heal. The orthoses must be non elastic. 
 
Laser therapy and Acupuncture:                                                                                      
          Laser waves are delivered to the tendons through any of the three 
modes given below: 
1. LLLT-Low level laser therapy 
2. LED-Light emitting diodes 
3. SLD-Super luminous diodes 
           Short term follow up trials on laser therapy have shown 
inconsistent results and long term follow up trails have shown that laser 
therapy has no benefit for lateral epicondylitis management. Researches 
on acupuncture therapy have found positive short term effects and these 
benefits last only for few weeks. 
Surgical Treatment:
 
 
      Surgical treatment for tennis elbow is done rarely. It is the last line 
of management when conservative treatment fails [17,19,22,23,32]. If 
symptoms persist after eight to 12 months, surgical management is 
recommended. The surgical techniques used by orthopedic surgeons are 
open, percutaneous and arthroscopic techniques. 
 
Surgical treatment falls into three basic categories: 
1. Release of common extensor origin 
2. Resection of degenerate or ruptured tendon with repair of defect 
3. Thermal disruption of degenerated tissue within the tendon 
 Elbow Open Surgery: 
Open debridement is performed to remove degenerative part of the 
extensor carpi radialis brevis tendon by making a surgical incision at the 
lateral epicondyle, and after excising the damaged tissues, the remaining 
tendon is reattached. This procedure gives success rate of 80 to 85 %.  In 
some cases, an operative procedure is performed to release the common 
extensor tendon. Approximately 80% of patients report good results 
following an open procedure and over 90% success is reported for a 
percuteneous release. Thermal disruption of the degenerative tendon has 
been reported to be beneficial. The procedure should not be performed 
under local anaesthesia, as patients can experience considerable pain 
during the application of probe’s impulse within the tendon.  
      Post operative management differs little among surgical techniques. 
Sling, splint or soft bandages are applied for the initial two weeks after 
surgery. Aims of rehabilitation after the surgical procedure are to improve 
range of movement and to increase the strength of the soft tissues around 
the elbow in four to six weeks. 
Arthroscopic lateral release: 
        With the advances that have been made with arthroscopy, 
indications have come to include arthroscopic lateral release and 
debridement. Advantages of this technique include the ability to visualize 
the articular surfaces for other occult pathology. 
Complications of surgical treatment: 
• Infection 
• Neurovascular injury 
• Possible prolonged rehabilitation 
• Loss of strength 
• Loss of range of motion 
• The need for further surgery 
• Synovial fistula (2% ) 
•  
  
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
5. MATERIALS AND METHODS 
This is a prospective study of about 40 patients includes 26 females 
and 14 males who were diagnosed as lateral epicondylitis for the period 
from March 2014 to June 2014 at Coimbatore Medical College Hospital, 
Coimbatore. 
         The present study attempts to compare the effectiveness of platelet 
rich plasma injection verses corticosteriod injection as a treatment for 
lateral epicondylitis. 
DRUGS USED: 
   3-4ml autologus platelet rich plasma. 
  Triamcinolone acetonide (40mg/ml). 1ml (40mg) of 
Triamcinolone acetonide is taken with 2ml of Lignocaine   (1 %) 
10mg/ml.  
PLATELET RICH PLASMA PREPARATION: 
  The platelet rich plasma preparation has been done using desktop-
size centrifuge apparatus. 27 ml of whole blood is withdrawn from the 
patient with 18 gauge needle. Blood is equally divided into three parts 
(nine ml each) which is then added to three pre filled test tubes, each 
containing one ml of 3.8% of sodium citrate solution. The blood is 
centrifuged at 1500 rpm for 15 minutes. By the end of the procedure the 
whole blood is separated into three layers such as platelet poor plasma 
(PPP), platelet rich plasma (PRP) and red blood cells (RBC). Platelet rich 
plasma is withdrawn from the middle layer. 
Eligibility for injection therapy: 
Age eligibility for study: 18 years and  above 
Genders:  Both male and female
 Healthy volunteers:  Not accepted 
Criteria for injection therapy: 
Inclusion criteria are 
• Duration of pain over lateral epicondyle  more than three months   
• Lateral elbow pain that is maximum at the lateral epicondyle and 
the pain is aggravated with pressure on the lateral epicondyle and 
resisted wrist dorsiflexion. 
 
 
Exclusion criteria are 
• Chronic inflammatory disease like Rheumatoid arthritis.  
• Fibromyalgia.  
• Pain in hand or shoulder or neck in the same upper limb.  
• Uncontrolled diabetes and systemic hypertension. 
• On anticoagulation therapy.  
• Ulcers over the elbow.  
• Steroid injection within the last three months. 
• Tumors in upper limb. 
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OUTCOME MEASURES: 
The   Patient’s clinical outcome is measured by using two self 
report quitionarries at each review period. 1. The Disabilities of the Arm, 
Shoulder and Hand (DASH) outcome score. 2. Visual analog scale (VAS) 
score to assess pain and functional outcome in lateral epicondylitis. 
  Disabilities of the Arm, Shoulder and Hand Score (DASH):       
The Disabilities of the Arm, Shoulder and Hand score has 30 items 
with self report questionnaires structured to assess physical activity and 
symptoms in persons who have musculoskeletal problems of the upper 
limbs. These items indicates the magnitude of difficulty in doing different 
functional activities since this score contains the questionnaires related to 
arm, shoulder, or hand problems of the affected upper limb (21 items), 
the severity of each of the symptoms of pain, activity related pain, 
weakness, tingling, and stiffness (five items), and the problem’s effect on 
social activities, daily work, and sleep and its psychological effect (four 
items).  
       The Disabilities of the Arm, Shoulder and Hand also assess two 
optional four items scales assessing the capability to do sports activity 
and to play a musical instrument (sport/music scale), and the capability to 
work (work scale). In this study, the two optional scales are not included 
in the analysis. The scores for 30 items are taken to calculate a total score 
ranging from 0 (no disability) to 100 (severest disability).       
Disability or symptom score: 
Minimum 27 of the 30 items should be completed for a score to be 
calculated. The calculated values for all completed items are added and 
averaged, to make a score out of five. 
This value is then converted to a score out of 100 by subtracting 
one and multiplying by 25. This conversion is carried out to make the 
score easier to compare with VAS on a 0 to100 scale. A high score 
indicates severe disability. 
DASH disability or symptom score = [(sum of n responses) - 1] /n x 25  
where n is equal to the number of completed responses. 
Visual Analogue Scale (VAS):          
      A Visual Analogue Scale (VAS) is a measuring scale that tries to 
measure a characteristic or attitude of pain that is believed to range across 
a continuous spectrum of values and cannot be measured directly. 
Simply, it is a measuring scale to quantify the amount of various pain 
notified by the patients. Scores range from 0 (no pain) to 100  (severest 
pain). The amount of pain that a patient indicates can range across a 
continuous spectrum from none to severest amount of pain. From the 
patient's perspective, this spectrum appears as continuous and their pain 
does not take discrete value as a classification of none, mild, moderate 
and severe. Visual Analogue Scale is used to make out this idea of an 
underlying continuous spectrum of pain in patients. 
          Operationally a Visual Analogue Scale is often a horizontal line, 
100 mm in length, written with word description at each end. Patients 
make a mark on the line, the point that they feel indicates their perception 
of their current pain value. The Visual Analogue Scale score is recorded 
by measuring in millimeters from the right side end of the line to the 
point that the patient marks.  
          Outcome is measured by the changes in pain measured by Visual 
Analogue Scale   and Disabilities of the Arm, Shoulder and Hand Score 
with the time period of pre injection, four weeks, eight weeks and 12 
weeks.  
The adverse events are recorded throughout the entire 12 weeks.  
                                        
                              
VISUAL ANALOGUE SCALE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
THE DISABILITIES OF THE ARM, SHOULDER AND HAND 
SCORE 
1 Open a tight jar 
or new jar 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
2 
Write 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
3 
Turn a key 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
4 
Prepare a meal 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
5 Push open a 
heavy door 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
6 Place an object 
on a shelf above 
the level of 
head 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
7 Do heavy 
household jobs 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
8 Garden or yard 
work 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
9 
Make a bed 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
10 Carry a 
shopping bag or 
briefcase 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
11 Carry a heavy 
object 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
12 Change a 
lightbulb 
overhead 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
13 Wash or blow 
dry your hair 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
14 
Wash your back 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
15 Put on a 
pullover 
sweater 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
16 Use a knife to 
cut food 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
17 Recreational 
activities which 
require little 
effort ( eg. 
knitting, card 
playing ) 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
18 Recreational 
activities in 
which you take 
some forces or 
impacts through 
your arm, 
shoulder or 
hand ( eg. 
hammering, 
tennis etc ) 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
19 Recreational 
activities in 
which you 
move your arm 
freely ( eg. 
playing 
badminton) 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
20 Manage 
transposition 
needs ( getting 
one place to 
another place) 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
21 
Sexual activities 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult unable 
22 During the past 
week, to what 
extent your arm, 
shoulder or 
hand problem 
interfered with 
your normal 
social activities 
with family, 
friends, 
neighbours or 
groups? 
 
 
 
 
 
 
not at all 
 
 
 
 
 
 
slightly 
 
 
 
 
 
 
moderately 
 
 
 
 
 
 
quit a 
bit 
 
 
 
 
 
 
 
extremely                         
23 During past 
week were you 
limited in your 
work or other 
regular daily 
activities as a 
result of your 
arm, shoulder or 
hand problem? 
not 
limited 
slightly 
limited 
moderately 
limited 
very 
limited 
 
 
 
 
 
unable                              
24 Arm, shoulder 
or hand pain none mild moderate severe 
              
extreme 
 25 Arm, shoulder 
or hand pain 
when you 
performed any 
specific 
activity? none mild moderate severe 
 
 
extreme 
26 Tingling( pins 
and needles ) in 
your arm, 
shoulder or 
hand none mild moderate severe 
 
 
     
extreme 
27 Weakness in 
your arm, 
shoulder or 
hand none mild moderate severe 
 
 
extreme 
28 Stiffness in arm, 
shoulder or 
hand none mild moderate severe 
 
extreme 
29 During the past 
week how much 
difficulty have 
you had 
sleeping 
because of pain 
no 
difficulty 
mildly 
difficult 
moderately 
difficult 
severely 
difficult 
 
 
 
 
in your arm, 
shoulder or 
hand? 
 so much I 
can’t sleep 
30 I feel less 
capable , less 
confident or less 
useful because 
of my arm, 
shoulder or 
hand 
strongly 
disagree 
disagree 
 
neither 
agree or 
disagree agree 
 
 
 
strongly 
agree 
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6. ANALYSIS OF DATA 
PATIENTS: 
Between the above mentioned period, 40 cases of lateral 
epicondylitis who met the above criteria were included for the study. 
 There were 26 females with 18 right side lateral epicondylitis and 
8 left side lateral epicondylitis and 14 males with 11 right side lateral 
epicondylitis and 3 left side lateral epicondylitis. The mean age was 44.3 
years and the range was 30 to 67 years. The mean duration of symptom 
was 4.8 months. 
INJECTION PROTOCOL: 
• Patients who met the inclusion criteria were randomly allocated 
into two groups by a lot method.    
• Consent was obtained from the patients after explaining the 
study, benefits and complications of the procedure and 
regarding the need for regular follow up. 
• Fresh blood was drawn from the platelet rich plasma (PRP) 
group patients (about 27 ml) and anticoagulant (three ml) is 
added. Then blood was centrifuged at 1500 rpm for 
approximately 15 minutes and 3 – 4 ml of platelet rich plasma 
was prepared. 
• pre injection and post injection score were calculated. 
INJECTION TECHNIQUE:  
•   The procedure was done on an outpatient basis. Once the exact 
location was determined by assessing the maximum tenderness point 
clinically, the patient was injected with a local anesthetic drug 
(Lignocaine) under sterile technique. Platelet rich plasma group was 
injected with 3-4 ml platelet rich plasma, using a “peppering” 
technique in a clock wise manner to better cover the affected area of 
lateral epicondyle. 
•  Triamcinolone acetonide (40mg/ml). One ml (40mg) of 
Triamcinolone acetonide is taken with two ml of Lignocaine (1%, 
10mg/ml). It was injected in the maximum tenderness point deep into 
the tendon.  
The patient was then observed for 15 to 20 minutes and then 
discharged.  After the injection, patient was allowed to follow our post 
injection protocol. 
POST INJECTION PROTOCOL: 
Since the patients may experience discomfort at the site of the 
injection for up to three days, they are advised to have ice fermentation 
over the injection site, limb elevation, activity modification and oral 
acetaminophen for pain relief. 
 FOLLOW UP:   
 All the patients were followed up at fourth, eighth and twelfth 
week of post injection. 
 One patient did not return for final follow up in platelet rich 
plasma (PRP) group. 
 At follow up, pain was assessed according to Visual Analogue 
Scale (VAS) and Disabilities of the Arm, Shoulder and Hand 
(DASH) score and compared with pre injection score levels. 
 Final outcome was measured based on the pain reduction from 
the pre injection level. 
 Patients were observed for post injection complications. 
 
COMPLICATIONS: 
1. In steroid group one patient had paraesthesia at the injection 
site of elbow at fourth week post injection but it disappeared 
at twelfth week with observation. 
2. No case of infection, cellulitis was observed. 
3. No neurovascular injury noted 
 
 
 
 
 
 
 
 
 
 
SEX DISTRIBUTION:     
Male: 14 
Female: 26 
                                   
 
SEX DISTRIBUTION                                       
 
 
 
 
 
 
 
 
 
SIDE DISTRIBUTION:  
Right: 29 
Left: 11 
 
SIDE DISTRIBUTION 
                                   
 
 
 
 
AGE DISTRIBUTION IN YEARS 
 
 
 
AGE IN YEARS NUMBER OF PATIENTS 
21-30 1 
31-40 14 
41-50 17 
51-60 6 
61-70 2 
PRE INJECTION SCORE: 
The average pre injection scores were: 
1. Platelet rich plasma injection group: 
  VAS: 66.6 
  DASH: 56.4 
2. Steroid injection group: 
 VAS: 65.5 
 DASH: 55.2 
The average pre injection scores 
 
POST INJECTION SCORE: 
 The average post injection scores at 4 weeks were: 
1. Platelet rich plasma injection group: 
  VAS: 54.5 
  DASH: 43.4 
2. Steroid injection group: 
 VAS: 47.6 
 DASH: 42.0 
                       The average post injection scores at 4 weeks  
  
 
 
 
 
 
The average post injection scores at 8 weeks were: 
1. Platelet rich plasma injection group: 
  VAS: 44.1 
  DASH: 34.8 
2. Steroid injection group: 
 VAS: 43.3 
 DASH: 35.8  
               
The average post injection scores at 8 weeks 
           
The average post injection scores at 12 weeks were: 
1. Platelet rich plasma injection group: 
  VAS: 36.5 
  DASH: 29.1 
2. Steroid injection group: 
 VAS: 37.8 
 DASH: 34.0 
The average post injection scores at 12 weeks 
 
 
 
RESULTS: 
All the relevant data’s were analyzed. 
The average Visual Analogue Scale  (VAS) and Disabilities of the Arm, 
Shoulder and Hand (DASH) scores in both the groups of pre injection, 
four, eight and 12 weeks post injection are shown in the below tables: 
 
PLATELET RICH PLASMA GROUP 
Pre injection 
score 
Post injection 
score (4 weeks) 
Post injection 
score (8 weeks) 
Post injection 
score (12 weeks) 
VAS   DASH VAS DASH VAS DASH VAS DASH 
66.6 56.4 54.5 43.4 44.1 34.8 36.5 29.1 
 
STERIOD GROUP 
Pre injection 
score 
Post injection 
score (4 weeks) 
Post injection 
score (8 weeks) 
Post injection 
score (12 weeks) 
VAS   DASH VAS DASH VAS DASH VAS DASH 
65.5 55.2 47.6 42.0 43.3 35.8 37.8 34.0 
      The effects of our injection observed with the Visual Analogue Scale 
(VAS) and Disabilities of the Arm, Shoulder and Hand (DASH) scores in 
the both the groups is depicted in a graph given below. 
                                     PLATELET RICH PLASMA GROUP 
 
 
                                                                                         
 
 
 
PLATELET RICH PLASMA GROUP 
Pre injection 
score 
Post injection 
score (4 weeks) 
Post injection 
score (8 weeks) 
Post injection 
score (12 weeks) 
VAS DASH VAS DASH VAS DASH VAS DASH 
66.6 56.4 54.5 43.4 44.1 34.8 36.5 29.1 
STERIODS GROUP 
 
 
STERIOD GROUP 
Pre injection 
score 
Post injection 
score (4 weeks) 
Post injection 
score (8 weeks) 
Post injection 
score (12 weeks) 
VAS DASH VAS DASH VAS DASH VAS DASH 
65.5 55.2 47.6 42.0 43.3 35.8 37.8 34.0 
       
From the above curves, it is clear that the steroid group had a steep 
curve than PRP group indicating the faster relief of pain initially. But at 
the end of 12 weeks follow up the steroid group shows flat curve pattern 
whereas the platelet rich plasma group shows falling curve pattern. 
VAS COMPARISON IN BOTH PLATELET RICH PLASMA GROUP AND 
STERIOD GROUP 
 
 
 
 
 
      
 
 
Visual Analogue Scale (VAS) in carticosteriod group decreases at 
four and eight weeks and increases at the end of 12 weeks comparative to 
platelet rich plasma group. 
 
 
 
 
DASH COMPARISON IN BOTH PLATELET RICH PLASMA GROUP AND 
STERIOD GROUP 
 
 
 
  
 
 
 
Disabilities of the Arm, Shoulder and Hand (DASH) score in 
carticosteriod group decreases at fourth week and increases at the end of 
twelfth week comparative to platelet rich plasma group. 
 
IN THIS STUDY, THE VISUAL ANALOGUE SCALE (VAS) 
SCORE IN PLATELET RICH PLASMA GROUP IS DECREASED BY 
30.1 AND THE DISABILITIES OF THE ARM, SHOULDER AND 
HAND (DASH) SCORE IS DECREASED BY 27.3 AT 12 WEEKS 
COMPARED TO THE PRE INJECTION SCORE. 
 WHEREAS THE VISUAL ANALOGUE SCALE (VAS) SCORE 
IN STERIOD GROUP IS DECREASED BY 27.7 AND THE 
DISABILITIES OF THE ARM, SHOULDER AND HAND (DASH) 
SCORE IS DECREASED BY 21.2 AT 12 WEEKS COMPARED TO 
THE PRE INJECTION SCORE. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
DISCUSSION 
7. DISCUSSION 
       Lateral epicondylitis is an inflammatory condition at the origin of the 
extensor tendon of forearm muscles over the lateral epicondyle. It is the 
commonest chronic disabling painful condition of the elbow. It causes 
symptoms in 1% to 3% of the general population. It is common in people 
whose occupation requires frequent rotary motion of the forearm like in 
carpenter, gardener, computer workers and knitting workers. The age of 
onset of lateral epicondylitis is between 35 and 50 years with an equal 
male to female sex ratio. The dominant upper limb is most commonly 
affected. 
                The actual cause of lateral epicondylitis is not clearly 
understood. Now it is considered that degenerative process occurs at the 
common extensor tendon origin of the wrist and fingers due to overuse 
and abnormal micro vascular responses [4,5,6]. Nirschl observed that the 
basic pathology was in the origin of the extensor carpi radialis brevis 
(ECRB) tendon. But sometimes the anteromedial edge of extensor 
digitorum communis (EDC) and the deep surface of extensor carpi 
radialis longus (ECRL) may also be involved.  
               Various modalities of treatment have been recommended for 
lateral epicondylitis. They are rest, activity modification, non steroidal 
anti inflammatory drugs, counterforce braces, massage, physiotherapy, 
laser treatment, extracorporeal shockwave treatment, acupuncture, 
ultrasound treatment and botulinum toxin type A injection. Injection of 
corticosteroids was thought to be the gold standard treatment in lateral 
epicondyliis previously. The autologus blood injection and different types 
of open and arthroscopic operative treatment are also advised for lateral 
epicondylitis [7,8,9,10,11]. At present, platelet rich plasma (PRP) is 
considered as an ideal biological autologous blood derived component. 
Platelet rich plasma has been utilised and studied since 1970. It can be 
injected in different tissues where, platelet is activated and it releases high 
concentrations of transforming growth factor-beta (TGF-β), platelet 
derived growth factors (PDGF), fibroblast growth factors (FGF), vascular 
endothelial growth factors (VEGF) and cytokines at the injected site. 
These growth factors play significant roles in cell proliferation, 
chemotaxis, cell differentiation and angiogenesis. Bioactive factors like 
serotonin, histamine, dopamine, calcium and adenosine are also stored in 
the dense granules in platelets. These non growth factors plays important 
role on the biological aspects of wound healing. The platelets in platelet 
rich plasma are delivered in a clot, which contains several cell adhesion 
molecules including fibronectin, fibrin and vitronectin. These cell 
adhesion molecules promote cell migration, and potentiate biological 
activity of platelet rich plasma. The clot itself promotes wound healing by 
acting as conductive matrix or scaffold upon which cells can adhere and 
initiate the wound healing process [12]. In addition, platelet rich plasma 
has high antimicrobial potency and this property may prevent infections. 
   There are less number of studies regarding the benefits of platelet rich 
plasma injection over corticosteroid injection therapy for lateral 
epicondylitis. The main outcome parameters considered were pain and 
functional activities of elbow. Currently long term follow up data’s 
regarding the effectiveness of platelet rich plasma are lacking. This study 
shows three months follow up results using the same outcome 
parameters. 
       In the study by Gosen et al march 2011, compared the effectiveness 
of autologous platelet rich plasma injection to steroid injection therapy in 
lateral epicondylitis, it is proved that platelet rich plasma injection is safe 
and easy.  Concerning functional impairment, the corticosteroid group 
showed better results during the initial period and then declined to 
baseline level. Whereas in platelet rich plasma group symptoms improved 
progressively. There was a significant difference in decrease of pain and 
functional impairment after platelet rich plasma application even after 
one year. 
      In this study the DASH score among platelet rich plasma group has 
declined from pre injection score of 56.4 to 43.4 at 4 weeks, 34.8 at 8 
weeks and 29.1 at 12 weeks which is almost similar to the study by 
Gosen et al march 2011, where the pre injection DASH score is 54.3 
which declines to 43.1 at 4 weeks, 31.2 at 12 weeks. 
   In this study the VAS score among platelet rich plasma group has 
declined from the pre injection score of 66.6 to 54.5 at 4 weeks, 44.1 at 8 
weeks and 36.5 at 12 weeks which is almost similar to the study by 
Gosen et al march 2011, where the pre-injection VAS score of 69.0 
declines to 55.7 at 4 weeks, 45.1 at 8 weeks and 40.2 at 12 weeks. 
   In this study the DASH score among steroid group started to decline 
from the pre injection score of 55.2 to 42.0 at 4 weeks ,35.8 at 8 weeks 
and  34.0 at 12 weeks,  whereas in the study by Gosen et al march 2011, 
DASH score among steroid group decline similarly up to 12 weeks . 
  In this study the VAS score among steroid group declines from 65.5 of 
pre injection score to 47.6 at 4 weeks, 43.3 at 8 weeks and 38.4 at 12 
weeks, whereas in the study by Gosen et al march 2011, the decline of 
VAS score from pre injection score of 66.2 to 44.3 at 4 weeks and 38.5 at 
12 weeks. 
    Comparing the results prescribed in this study with the results of three 
months follow up, the outcome in the corticosteroid group is declined, 
whereas the outcome in the platelet rich plasma group is maintained. A 
significant finding is that the platelet rich plasma group had worse pre 
injection VAS scores and better after 12 weeks. This strengthens our 
conclusion that the platelet rich plasma injection is better than 
corticosteroid injection. 
       In the Mishra and Pavelko research, the success rate was 93% in the 
platelet rich plasma group and 65% success rate for steroid group in the 
Hay et al study. 
          In this study out of 40 patients, one patient didn't return for follow 
up in platelet rich plasma group and the post procedure complication is 
negligible except for one patient who presented with paraesthesia at 
steroid injection site which resolved at twelfth week. 
 
                                                     
  
 
 
 
 
 
 
 
 
      CONCLUSION 
8. CONCLUSION 
 In conclusion, the comparative study of treatment of lateral 
epicondylitis with platelet rich plasma verses corticosteroid injection 
shows that a single injection of autologous platelet rich plasma improves 
elbow pain and functional activities more effectively than corticosteroid 
injection in lateral epicondylitis. These improvements were maintained 
over in our follow up period without any significant complications.   
 Corticosteroid gives better results up to eighth week and after that 
pain decreased slightly. Long term follow up with more number of 
patients is needed to evaluate lasting benefits of pain relief and functional 
improvement in lateral epicondylitis. 
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MASTER CHART      
MASTER CHART 
 
S.NO O.PNO 
AG
E 
SEX 
M/F 
SIDE 
L/R 
DURATION 
MONTHS 
DRUG 
P/S 
PRE 
INJECTION 
SCORE 
POST 
INJECTION 
4WEEKS 
POST  
INJECTION 
8 WEEKS 
POST  
INJECTION 
12 WEEKS 
       VAS 
DASH 
 
VAS DASH VAS DASH VAS DASH 
1. 11837 53 F R 4.5 P 66 57 54 50 46 47 42 33 
2. 57120 42 M R 6 P 63 52 47 46 44 37 31 32 
3.. 12755 40 F L 6.5 S 70 61 48 43 44 38 40 31 
4. 7318 48 F R 3 P 64 63 50 42 46 30 36 28 
5. 29828 40 F L 3.5 S 67 52 46 32 42 34 48 30 
6. 9644 50 F L 4.5 S 70 64 54 50 48 42 38 36 
7. 36093 37 F R 4 P 79 69 48 37 47 30 30 28 
8. 49532 42 M L 5 S 63 56 41 44 38 34 40 37 
9. 5572 46 F R 5 P 65 60 48 47 42 36 38 26 
10. 32254 48 M R 6 S 64 52 48 40 50 34 38 36 
11. 35752 38 M R 4 S 62 68 57 58 48 44 38 35 
12. 25962 44 M R 8 P 76 63 62 45 49 35 46 32 
13. 6405 47 F R 3.5 P 70 59 53 42 40 36 35 25 
14. 7708 46 M R 4 S 64 50 41 36 44 37 31 34 
15. 58388 43 M R 5 P 74 60 57 49 48 37 36 27 
16. 67207 50 M R 4.5 S 76 54 53 49 48 42 38 36 
17. 31890 52 F R 4 S 60 53 43 41 43 32 38 31 
18. 16096 36 M R 3 P 64 70 56 40 47 38 39 32 
19. 20481 49 M L 3.5 P 75 69 46 41 46 40 41 32 
20. 98801 55 F L 4 S 66 62 53 54 47 44 38 28 
21. 21671 38 F L 5.5 P 67 56 53 40 43 32 38 33 
22. 20242 44 F R 6 P 72 62 58 44 41 30 34 36 
23. 35489 35 F L 7 S 70 64 56 50 44 42 38 36 
24. 10911 65 M R 5.5 P 75 51 49 34 40 29 23 22 
25. 23951 52 F R 8 S 57 54 45 38 39 32 39 33 
26. 24567 51 F R 3.5 S 61 50 42 34 43 30 37 39 
27. 42772 44 F L 5.5 S 65 47 44 31 40 30 36 32 
28. 21240 45 M R 6 P 70 52 53 41 47 33 35 27 
29. 24901 39 M R 4.5 S 69 50 49 39 45 30 35 32 
30. 22116 33 F R 3.5 P 72 52 50 47 43 32 44 26 
31. 35363 39 F R 3 P 66 51 53 47 40 41 39 33 
32. 43590 30 F R 4 S 61 54 40 38 38 36 36 35 
33. 5677 67 M L 3.5 S 69 53 53 49 37 32 33 28 
34. 24124 46 F R 6 P 70 52 54 45 44 37 41 35 
35. 25972 38 F R 7 P 74 69 55 39 43 32 LF LF 
36. 5233 35 F R 5.5 P 67 60 49 50 45 37 34 22 
37. 26064 41 F L 4 P 70 52 51 41 40 27 35 22 
38. 25976 33 F R 4.5 S 69 59 43 31 48 30 39 37 
39. 23760 40 F R 3.5 S 60 50 48 37 40 39 36 37 
40. 21141 53 F R 4 S 67 51 48 46 39 34 39 36 
 
KEY:                                                                            
 L- Left       
 R-Right     
 M-Male 
 F-Female  
 P-Platelet rich plasma  
 S-Steroid  
 VAS-Visual Analog Scale  
 DASH- Disabilities of the Arm Shoulder Hand score 
 LF- Lost follow up 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
PROFORMA 
PROFORMA 
NAME:                                                                          S.NO: 
AGE:                                                                             OP.NO: 
SEX: 
OCCUPATION: 
PAIN DURATION:                                                       PHONE NO: 
SIDE: 
DRUG:                                                                          ADDRESS: 
 
 
Pre injection Post injection 
(4 weeks) 
Post injection 
(8 weeks) 
Post injection 
(12 weeks) 
VAS   DASH VAS DASH VAS DASH VAS DASH 
        
 
COMPLICATIONS: 
